According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is 0,80ย โฌ. In 2024 the company made an earnings per share (EPS) of 0,91ย โฌ an increase over its 2023 EPS that were of 0,75ย โฌ.